Contact Us
Drug Search Results
Using advanced filters...
Advanced Search [+]

ORIN-1001

Alternative Names: orin-1001, orin1001, orin 1001
Latest Update: 2024-12-31
Latest Update Note: Clinical Trial Update

Product Description

Orinove is developing ORIN-1001 (Abraxane) as a treatment for Advanced Solid Tumors and Metastatic Breast Cancer. (Sourced from: https://classic.clinicaltrials.gov/ct2/show/NCT03950570)

Mechanisms of Action: IRE1 Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Orinove
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ORIN-1001

Countries in Clinic: China, United States

Active Clinical Trial Count: 3

Highest Development Phases

Phase 2: Breast Cancer|Esophageal Cancer|Hepatocellular Carcinoma|Non-Small-Cell Lung Cancer|Ovarian Cancer|Pancreatic Cancer|Prostate Cancer|Small Cell Lung Cancer|Triple Negative Breast Cancer

Phase 1: Oncology Solid Tumor Unspecified

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
ORIN1001-001

P2

Completed

Breast Cancer

2023-01-30

ORIN1001-C1

P2

Completed

Pancreatic Cancer|Prostate Cancer|Esophageal Cancer|Hepatocellular Carcinoma|Small Cell Lung Cancer|Non-Small-Cell Lung Cancer|Triple Negative Breast Cancer|Ovarian Cancer

2023-01-30

CTR20200281

P1

Recruiting

Oncology Solid Tumor Unspecified

None

Recent News Events

Date

Type

Title

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions